The Effect of Probiotics on Phototherapy for Bilirubin Reduction in Term Neonates: A Randomized Controlled Trial

Fatemeh Eghbalian1, Mohamad Kazem Sabzehei1, Soroush Taheri Talesh2

  • 1Departments of Pediatric, Hearing Disorders Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.

Current Pediatric Reviews
|November 6, 2023
PubMed

Insights

Combining probiotics with phototherapy significantly reduced treatment time and hospital stays for neonatal jaundice. This approach offers a more efficient treatment for term neonates suffering from elevated bilirubin levels.

Area of Science:

  • Neonatology
  • Gastroenterology
  • Pediatric Medicine

Background:

  • Neonatal jaundice is a common condition requiring effective treatment.
  • Phototherapy is a standard treatment, but its efficacy can be enhanced.
  • Combining therapies may offer improved outcomes for hyperbilirubinemia in newborns.

Purpose of the Study:

  • To evaluate the efficacy of combined probiotics and phototherapy versus phototherapy alone in reducing bilirubin levels in term neonates.
  • To compare treatment duration and hospitalization length between the two therapeutic approaches.

Main Methods:

  • A randomized clinical trial involving 150 term neonates diagnosed with jaundice.
  • Participants were assigned to receive either phototherapy with oral probiotics or phototherapy alone.
  • Serum bilirubin levels, phototherapy duration, hospitalization length, and need for blood transfusion were monitored and compared.

Main Results:

  • No significant difference in initial bilirubin levels or baseline characteristics between groups.
  • The combination group showed significantly lower serum bilirubin levels by day three.
  • The combinatory therapy group experienced shorter phototherapy durations (26.2 vs. 31.4 hours) and hospital stays (2.4 vs. 2.8 days).

Conclusions:

  • Oral probiotics combined with phototherapy effectively reduce treatment duration and hospital stay in term neonates with jaundice.
  • This combined approach presents a promising strategy for managing neonatal hyperbilirubinemia.
  • Further research may explore the long-term benefits and optimal probiotic strains for neonatal jaundice.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...